Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/122861

Beta release

Statistics of Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0500
2024-0600
2024-0700